Do lutein, zeaxanthin and macular pigment optical density differ with age or age-related maculopathy?

e-SPEN

Volumn 6, Issue 4, 2011, Pages

  Berrow, Emma J ^a,b   Bartlett, Hannah E ^a   Eperjesi, Frank ^a  

^a ASTON UNIVERSITY   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Age related macular disease; Lutein; Macular; Macular pigment; MPOD

Indexed keywords

XANTHOPHYLL; ZEAXANTHIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; GROUPS BY AGE; HUMAN; MACULAR PIGMENT OPTICAL DENSITY; MALE; OPTICAL DENSITY; PHOTOMETRY; QUESTIONNAIRE; RETINA MACULA AGE RELATED DEGENERATION; SMOKING HABIT;

EID: 83555174441     PISSN: None     EISSN: 17514991     Source Type: Journal    
DOI: 10.1016/j.eclnm.2011.05.003     Document Type: Article

References (43)

1. Bird A.C., Bressler N.M., Bressler S.B., Chisholm I.H., Coscas G., Davis M.D., et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol 1995, 39:367-374.
2. Evans J., Wormald R. Is the incidence of registrable age-related macular degeneration increasing?. Br J Ophthalmol 1996, 80:9-14.
3. Curcio C., Millican C. Basal linear deposit and large drusen are specific for early age-related maculopathy. Arch Ophthalmol 1999, 117:329-339.
4. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss - AREDS Report No. 8. Arch Ophthalmol 2001, 119:1417-1436. The AREDS Research Group.
5. Bone R., Landrum J., Tarsis S. Preliminary identification of the human macular pigment. Vis Res 1985, 25:1531-1535.
6. Hammond B.R., Wooten B.R., Snodderly D.M. Individual variations in the spatial profile of human macular pigment. J Opt Soc America a-Optics Image Sci Vis 1997, 14:1187-1196.
7. Snodderly D.M., Auran J., Delori F. The macular pigment II. Spatial distribution in primate retinas. Invest Ophthalmological Vis Sci 1984, 25:674-685.
8. Snodderly D.M., Brown B., Delori F. The macular pigment I. Absorbance spectra, localisation, and discrimination from other yellow pigments in primate retinas. Invest Ophthalmological Vis Sci 1984, 25:660-673.
9. Organisciak D.T., Vaughan D.K. Retinal light damage: mechanisms and protection. Prog Retin Eye Res 2009, 29:113-134.
10. Krinsky N.I., Deneke S.M. Interaction of oxygen and oxy-radicals with carotenoids. J Natl Cancer Inst 1982, 69:205-210.
11. Bone R.A., Landrum J.T., Mayne S.T., Gomez C.M., Tibor S.E., Twaroska E.E. Macular pigment in donor eyes with and without AMD: a case-control study. Invest Ophthalmol Vis Sci 2001, 42:235-240.
12. Delcourt C., Carriere I., Delage M., Barberger-Gateau P., Schalch W. Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the POLA study. Invest Ophthalmol Vis Sci 2006, 47:2329-2335.
13. Mares-Perlman J.A., Brady W.E., Klein R., Klein B.E.K., Bowen P., Stacewiczsapuntzakis M., et al. Serum antioxidants and age-related macular degeneration in a population-based case-controlled study. Arch Ophthalmol 1995, 113:1518-1523.
14. Mares-Perlman J.A., Klein R., Klein B.E.K., Greger J.L., Brady W.E., Palta M., et al. Association of zinc and antioxidant nutrients with age-related maculopathy. Arch Ophthalmol 1996, 114:991-997.
15. Richer S. ARMD-pilot (case series) environmental intervention data. J Am Optom Assoc 1999, 70:24-36.
16. Parisi V., Tedeschi M., Gallinaro G., Varano M., Saviano S., Piermarocchi S. Carotenoids and antioxidants in age-related maculopathy Italian study: multifocal electroretinogram modifications after 1 year. Ophthalmology 2008, 115:324-333. e322.
17. Bone R., Landrum J., Friedes L., Gomez C.M., Kilburn M.D., Menendez E., et al. Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp Eye Res 1997, 64:211-218.
18. Smith W., Assink J., Klein R., Mitchell P., Klaver C.C., Klein B.E., et al. Risk factors for age related macular degeneration - Pooled findings from three continents. Ophthalmology 2001, 108:697-704.
19. Risk factors associated with age-related macular degeneration - a case-control study in the age-related eye disease study: age- related eye disease study report number 3. Ophthalmology 2000, 107:2224-2232. The AREDS Research group.
20. Krishnaiah S., Das T., Nirmalan P.K., Nutheti R., Shamanna B.R., Rao G.N., et al. Risk factors for age-related macular degeneration: findings from the Andhra Pradesh eye disease study in South India. Invest Ophthalmol Vis Sci 2005, 46:4442-4449.
21. Song S.J., Youm D.J., Chang Y., Yu H.G. Age-related macular degeneration in a screened South Korean population: prevalence, risk factors, and subtypes. Ophthalmic Epidemiol 2009, 16:304-310.
22. Risk factors for neovascular age-related macular degeneration. The eye disease case control study group. Arch Ophthalmol 1992, 110:1701-1708. EDCCS Group.
23. Chakravarthy U., Augood C., Bentham G.C., de Jong P., Rahu M., Seland J., et al. Cigarette smoking and age-related macular degeneration in the EUREYE study. Ophthalmology 2007, 114:1157-1163.
24. Klein R., Knudtson M.D., Cruickshanks K.J., Klein B.E.K. Further observations on the association between smoking and the long-term incidence and progression of age-related macular degeneration. Arch Ophthalmol 2008, 126:115-121.
25. Neuner B., Komm A., Wellmann J., Dietzel M., Pauleikhoff D., Walter J., et al. Smoking history and the incidence of age-related macular degeneration-results from the Muenster aging and retina study (MARS) cohort and systematic review and meta-analysis of observational longitudinal studies. Addict Behav 2009, 34:938-947.
26. Coleman A.L., Seitzman R.L., Cummings S.R., Yu F., Cauley J.A., Ensrud K.E., et al. The association of smoking and alcohol use with age-related macular degeneration in the oldest old: the study of osteoporotic fractures. Am J Ophthalmol 2010, 149:160-169.
27. Yoshimura N. Age-related macular degeneration and genetics. Clin Exp Ophthalmol 2010, 38:1.
28. Katta S., Kaur I., Chakrabarti S. The molecular genetic basis of age-related macular degeneration: an overview. J Genet 2009, 88:425-449.
29. Meyers S. A twin study on age-related macular degeneration. Trans Am Ophthalmol Soc 1994, 92:775-844.
30. Newcombe R.G., Duff G.R. Eyes or patients - traps for the unwary in the statistical-analysis of ophthalmological studies. Br J Ophthalmol 1987, 71:645-646.
31. Bartlett H., Stainer L., Singh S., Eperjesi F., Howells O. Clinical evaluation of the MPS 9000 macular pigment Screener. Br J Ophthalmol 2010, 94:753-756.
32. Nolan J.M., Stack J., O' Donovan O., Loane E., Beatty S. Risk factors for age-related maculopathy are associated with a relative lack of macular pigment. Exp Eye Res 2007, 84:61-74.
33. Beatty S., Murray I.J., Henson D.B., Carden D., Koh H., Boulton M.E. Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci 2001, 42:439-446.
34. Nolan J.M., Kenny R., O'Regan C., Cronin H., Loughman J., Connolly E.E., et al. Macular pigment optical density in an ageing Irish population: the Irish longitudinal study on ageing. Ophthalmic Res 2010, 44:131-139.
35. Ciulla T.A., Hammond B.R. Macular pigment density and aging, assessed in the normal elderly and those with cataracts and age-related macular degeneration. Am J Ophthalmol 2004, 138:582-587.
36. Berendschot T.T., Willemse-Assink J.J., Bastiaanse M., de Jong P.T., van Norren D. Macular pigment and melanin in age-related maculopathy in a general population. Invest Ophthalmol Vis Sci 2002, 43:1928-1932.
37. Tang C.Y., Yip H.S., Poon M.Y., Yau W.L., Yap M.K. Macular pigment optical density in young Chinese adults. Ophthalmic Physiol Opt 2004, 24:586-593.
38. Kirby M.L., Beatty S., Loane E., Akkali M.C., Connolly E.E., Stack J., et al. A central dip in the macular pigment spatial profile is associated with age and smoking. Invest Ophthalmol Vis Sci 2010, 51:6722-6728.
39. Seddon J.M., Ajani U.A., Sperduto R.D., Hiller R., Blair N., Burton T.C., et al. Dietary carotenoids, vitamin A, C and E and advanced age-related macular degeneration. Jama-Journal Am Med Assoc 1994, 272:1413-1420.
40. Koh H.H., Murray I.J., Nolan D., Carden D., Feather J., Beatty S. Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study. Exp Eye Res 2004, 79:21-27.
41. Wenzel A.J., Gerweck C., Barbato D., Nicolosi R.J., Handelman G.J., Curran-Celentano J.A. 12-wk egg intervention increases serum zeaxanthin and macular pigment optical density in women. J Nutr 2006, 136:2568-2573.
42. Dietzel M., Zeimer M., Heimes B., Claes B., Pauleikhoff D., Hense H.W. Determinants of macular pigment optical density and its relation to age-related maculopathy - results from the Muenster aging and retina study (MARS). Invest Ophthalmol Vis Sci 2011.
43. Sibbald B., Roland M. Understanding controlled trials - why are randomised controlled trials important?. Br Med J 1998, 316:201.